Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cipla
Federal Trade Commission
Citi
Fish and Richardson
QuintilesIMS
Harvard Business School
Queensland Health
Express Scripts
Teva

Generated: December 11, 2017

DrugPatentWatch Database Preview

Patents Expiring in February 2022

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
J And J Consumer IncPEPCID ACfamotidineTABLET, CHEWABLE;ORAL020801-002Dec 17, 2007OTCYesYes► Subscribe► Subscribe► SubscribeY
J And J Consumer IncPEPCID COMPLETEcalcium carbonate; famotidine; magnesium hydroxideTABLET, CHEWABLE;ORAL020958-001Oct 16, 2000OTCYesYes► Subscribe► Subscribe► SubscribeY
CerexaAVYCAZavibactam sodium; ceftazidimePOWDER;IV (INFUSION)206494-001Feb 25, 2015RXYesYes► Subscribe► Subscribe► SubscribeYYMETHOD OF TREATING BACTERIAL INFECTIONS
Galderma Labs LpMETROGELmetronidazoleGEL;TOPICAL021789-001Jun 30, 2005ABRXYesYes► Subscribe► Subscribe► SubscribeYONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA
Intercept Pharms IncOCALIVAobeticholic acidTABLET;ORAL207999-001May 27, 2016RXYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC)
Galderma Labs LpMETROGELmetronidazoleGEL;TOPICAL021789-001Jun 30, 2005ABRXYesYes► Subscribe► Subscribe► SubscribeYONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA
Intercept Pharms IncOCALIVAobeticholic acidTABLET;ORAL207999-001May 27, 2016RXYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC)
Intercept Pharms IncOCALIVAobeticholic acidTABLET;ORAL207999-002May 27, 2016RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC)
Intercept Pharms IncOCALIVAobeticholic acidTABLET;ORAL207999-002May 27, 2016RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC)
Takeda Pharms NaPREVACID IVlansoprazoleINJECTABLE;INTRAVENOUS021566-001May 27, 2004DISCNYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Medtronic
US Department of Justice
Queensland Health
McKesson
Federal Trade Commission
Accenture
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot